These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7622938

  • 1. Serum beta 2-microglobulin in chronic diseases of the pancreas.
    Pezzilli R, Billi P, Fiocchi M, Beltrandi E, Cappelletti O, Sprovieri G, Miglioli M.
    Int J Pancreatol; 1995 Apr; 17(2):161-6. PubMed ID: 7622938
    [Abstract] [Full Text] [Related]

  • 2. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R, Billi P, Plate L, Laudadio MA, Sprovieri G.
    Ital J Gastroenterol; 1995 Apr; 27(6):296-9. PubMed ID: 8562994
    [Abstract] [Full Text] [Related]

  • 3. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R, Billi P, Beltrandi E, Mancini R, Casadei-Maldini M, Casadei R, Greco VM, Campione O, Miglioli M.
    Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
    [Abstract] [Full Text] [Related]

  • 4. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G, Spada OA, Rabitti PG, Feola B, Misso S, Minerva A, Uomo G.
    Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
    [Abstract] [Full Text] [Related]

  • 5. Serum pancreatic stone protein in pancreatic diseases.
    Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Sobajima H, Tanikawa M, Nakae Y, Hayakawa S, Katsuzaki T.
    Int J Pancreatol; 1993 Apr; 13(2):97-103. PubMed ID: 8501356
    [Abstract] [Full Text] [Related]

  • 6. Serum beta 2-microglobulin in malignant and benign diseases of the stomach and pancreas.
    Rashid SA, Cooper EH, Axon AT, Eaves G.
    Biomedicine; 1980 Apr; 33(4):112-6. PubMed ID: 6159008
    [Abstract] [Full Text] [Related]

  • 7. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer?
    Kayhan B, Kayhan B, Akdoğan M.
    Int J Biol Markers; 2004 Apr; 19(3):196-202. PubMed ID: 15503821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y, Kawakami H, Watanabe H, Satomura Y, Ohta H, Okai T, Makino H, Toya D, Sawabu N.
    Oncology; 1991 Apr; 48(4):321-6. PubMed ID: 1891175
    [Abstract] [Full Text] [Related]

  • 11. The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.
    Klein B, Levin I, Kfir B, Mishaeli M, Shapira J, Klein T.
    Tumour Biol; 1995 Apr; 16(5):290-6. PubMed ID: 7652467
    [Abstract] [Full Text] [Related]

  • 12. Serum soluble IL-6 receptor concentrations correlate with stages of multiple myeloma defined by serum beta 2-microglobulin and C-reactive protein.
    Kyriakou D, Papadaki H, Eliopoulos AG, Foudoulakis A, Alexandrakis M, Eliopoulos GD.
    Int J Hematol; 1997 Oct; 66(3):367-71. PubMed ID: 9401283
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum levels of pancreatitis-associated protein in digestive diseases with special reference to gastrointestinal cancers.
    Motoo Y, Satomura Y, Mouri I, Mouri H, Ohtsubo K, Sakai J, Fujii T, Taga H, Yamaguchi Y, Watanabe H, Okai T, Sawabu N.
    Dig Dis Sci; 1999 Jun; 44(6):1142-7. PubMed ID: 10389686
    [Abstract] [Full Text] [Related]

  • 15. Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.
    Mehta PD, Kulczycki J, Mehta SP, Sobczyk W, Coyle PK, Sersen EA, Wisniewski HM.
    Clin Immunol Immunopathol; 1992 Oct; 65(1):53-9. PubMed ID: 1382909
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of serum elastase 1 in pancreatic disease.
    Gullo L, Ventrucci M, Pezzilli R, Platé L, Naldoni P.
    Br J Surg; 1987 Jan; 74(1):44-7. PubMed ID: 2435358
    [Abstract] [Full Text] [Related]

  • 17. Trypsin/creatinine clearance ratio and serum immunoreactive trypsin in digestive and pancreatic diseases.
    Del Favero G, Fabris C, Bonvicini P, Piccoli A, Baccaglini U, Pedrazzoli S, Burlina A, Naccarato R.
    Ric Clin Lab; 1985 Jan; 15(4):343-7. PubMed ID: 2422720
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of CA 19-9 and CA 50 in relation to Lewis blood cell status in patients with malignant and benign pancreatic disease.
    von Rosen A, Linder S, Harmenberg U, Pegert S.
    Pancreas; 1993 Mar; 8(2):160-5. PubMed ID: 8460090
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
    Sakamoto K, Haga Y, Yoshimura R, Egami H, Yokoyama Y, Akagi M.
    Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
    [Abstract] [Full Text] [Related]

  • 20. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis.
    Caforio AL, Goldman JH, Baig MK, Mahon NJ, Haven AJ, Souberbielle BE, Holt DW, Dalgleish AG, McKenna WJ.
    Eur J Heart Fail; 2001 Mar; 3(2):155-63. PubMed ID: 11246052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.